Li N, Zhang Y, Zhang Q, Jin H, Han M, Guo J
Sci Rep. 2025; 15(1):8688.
PMID: 40082583
PMC: 11906761.
DOI: 10.1038/s41598-025-93512-5.
Kos M, Bojarski K, Mertowska P, Mertowski S, Tomaka P, Dziki L
Int J Mol Sci. 2024; 25(17).
PMID: 39273213
PMC: 11394694.
DOI: 10.3390/ijms25179264.
Zhang Y, Zhu Y, Chen Y, Wang Y, Liu B, Pan Y
iScience. 2024; 27(2):109011.
PMID: 38357662
PMC: 10865395.
DOI: 10.1016/j.isci.2024.109011.
Liu X, Ren J, Zhou R, Wen Z, Wen Z, Chen Z
BMC Cancer. 2023; 23(1):1106.
PMID: 37957566
PMC: 10644585.
DOI: 10.1186/s12885-023-11569-9.
Cen K, Wu Z, Mai Y, Dai Y, Hong K, Guo Y
Front Genet. 2023; 14:1074900.
PMID: 37124616
PMC: 10141461.
DOI: 10.3389/fgene.2023.1074900.
Nomogram established using risk factors of early gastric cancer for predicting the lymph node metastasis.
Jiang X, Yao X, Xia H, Su Y, Luo P, Sun J
World J Gastrointest Oncol. 2023; 15(4):665-676.
PMID: 37123061
PMC: 10134212.
DOI: 10.4251/wjgo.v15.i4.665.
Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
Jiang F, Ma Q
Genet Res (Camb). 2023; 2023:4674536.
PMID: 36923953
PMC: 10010888.
DOI: 10.1155/2023/4674536.
HMMR promotes peritoneal implantation of gastric cancer by increasing cell-cell interactions.
Yang M, Chen B, Kong L, Chen X, Ouyang Y, Bai J
Discov Oncol. 2022; 13(1):81.
PMID: 36002694
PMC: 9402864.
DOI: 10.1007/s12672-022-00543-9.
Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer.
Zhu Y, Jiang Z, Wang B, Li Y, Jiang J, Zhong Y
Front Oncol. 2022; 12:841460.
PMID: 35425711
PMC: 9001840.
DOI: 10.3389/fonc.2022.841460.
Prognostic significance of α-fetoprotein in gastric adenocarcinoma.
Vatansever S, Ozer M, Erdogan E
Prz Gastroenterol. 2022; 17(1):35-40.
PMID: 35371353
PMC: 8942005.
DOI: 10.5114/pg.2022.114595.
BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling.
Zhou S, Zhang S, Wang L, Huang S, Yuan Y, Yang J
Oncogenesis. 2020; 9(3):33.
PMID: 32157097
PMC: 7064486.
DOI: 10.1038/s41389-020-0218-z.
The use of DNA repair genes as prognostic indicators of gastric cancer.
Jinjia C, Xiaoyu W, Hui S, Wenhua L, Zhe Z, Xiaodong Z
J Cancer. 2019; 10(20):4866-4875.
PMID: 31598158
PMC: 6775511.
DOI: 10.7150/jca.31062.
Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer.
Yang Z, Li J, Shi Y, Li L, Guo X
Oncol Lett. 2019; 17(3):2599-2606.
PMID: 30854035
PMC: 6365935.
DOI: 10.3892/ol.2019.9889.
Identification and validation of a prognostic 9-genes expression signature for gastric cancer.
Wang Z, Chen G, Wang Q, Lu W, Xu M
Oncotarget. 2017; 8(43):73826-73836.
PMID: 29088749
PMC: 5650304.
DOI: 10.18632/oncotarget.17764.
Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis.
Zu G, Zhang T, Li W, Sun Y, Zhang X
Clin Transl Oncol. 2017; 19(6):750-760.
PMID: 28054321
DOI: 10.1007/s12094-016-1600-3.
Upregulation of miR-222 in both Helicobacter pylori- infected and noninfected gastric cancer patients.
Noormohammad M, Sadeghi S, Tabatabaeian H, Ghaedi K, Talebi A, Azadeh M
J Genet. 2016; 95(4):991-995.
PMID: 27994199
DOI: 10.1007/s12041-016-0728-9.
Prognostic Factors of Patients With Transmural Advanced Gastric Carcinoma.
Derici H, Yaman I, Tansug T, Nazli O, Bozdag A, Isguder A
Gastroenterology Res. 2016; 2(6):317-323.
PMID: 27990200
PMC: 5139691.
DOI: 10.4021/gr2009.11.1322.
The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G, Zhou L, Zhang X, Zhu B, Wu S, Song W
World J Surg Oncol. 2016; 14(1):276.
PMID: 27793161
PMC: 5084408.
DOI: 10.1186/s12957-016-1033-z.
Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.
Alpizar-Alpizar W, Laerum O, Christensen I, Ovrebo K, Skarstein A, Hoyer-Hansen G
J Histochem Cytochem. 2016; 64(8):483-94.
PMID: 27370797
PMC: 4971780.
DOI: 10.1369/0022155416656173.
BET inhibition as a new strategy for the treatment of gastric cancer.
Montenegro R, Clark P, Howarth A, Wan X, Ceroni A, Siejka P
Oncotarget. 2016; 7(28):43997-44012.
PMID: 27259267
PMC: 5190074.
DOI: 10.18632/oncotarget.9766.